Severe febrile neutropenia associated with satralizumab in an Argentinian neuromyelitis optica spectrum disorder patient

Pestchanker, C; Diaconchuk, M; Lopez, P; Montaño, MR; Romero, W; Zalazar, G; Contentti, EC

Pestchanker, C (通讯作者),Hosp Cent Dr Ramon Carrillo, Neurol Dept, RA-5700 San Luis, Argentina.

MULTIPLE SCLEROSIS JOURNAL, 2023; 29 (1): 150

Abstract

Background: Recently, satralizumab (interleukin-6 receptor blocker) was approved for seropositive neuromyelitis optica spectrum disorder (NMOSD) patie......

Full Text Link